Process View
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to progesterone"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.956 | ||
EGFR | epidermal growth factor receptor | 0.424 | ||
JUNB | jun B proto-oncogene | 0.331 | ||
FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.271 | Rat | |
JUN | jun proto-oncogene | 0.249 | ||
NRP1 | neuropilin 1 | 0.230 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.208 | ||
GRB2 | growth factor receptor-bound protein 2 | 0.182 | ||
MED15 | mediator complex subunit 15 | 0.127 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.116 | ||
JDP2 | Jun dimerization protein 2 | 0.113 | ||
FYN | FYN oncogene related to SRC, FGR, YES | 0.098 | ||
TGFB1 | transforming growth factor, beta 1 | 0.081 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.055 | ||
TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.055 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.047 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.035 | ||
NCF1 | neutrophil cytosolic factor 1 | 0.034 | ||
NCOR2 | nuclear receptor corepressor 2 | 0.033 | ||
NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.028 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.028 | ||
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.024 | ||
ENG | endoglin | 0.024 | ||
EGR1 | early growth response 1 | 0.023 | ||
MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.023 | ||
MUC1 | mucin 1, cell surface associated | 0.022 | ||
PTEN | phosphatase and tensin homolog | 0.020 | ||
ATF3 | activating transcription factor 3 | 0.019 | ||
ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.018 | ||
JAK2 | Janus kinase 2 | 0.018 | ||
TICAM2 | toll-like receptor adaptor molecule 2 | 0.018 | ||
IER2 | immediate early response 2 | 0.017 | ||
SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.017 | ||
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.017 | ||
FSTL1 | follistatin-like 1 | 0.016 | ||
ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 | 0.016 | ||
SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.015 | ||
JUND | jun D proto-oncogene | 0.015 | ||
COMMD1 | copper metabolism (Murr1) domain containing 1 | 0.014 | ||
APP | amyloid beta (A4) precursor protein | 0.014 | ||
NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.013 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.013 | Rat | |
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.012 | ||
SPRR2A | small proline-rich protein 2A | 0.012 | ||
CUEDC2 | CUE domain containing 2 | 0.012 | ||
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.012 |